Funding for and access to clinical trials must be examined “though a lens of inclusion and communities of color,” advocate says.
Understanding the work of data monitoring and endpoint adjudication committees can open new career options for clinical trial practitioners, expert says.
“We need to understand what it will take for sites to be ready for DCTs.”
“Our stated goals for the industry are to make trials 25% faster and reduce costs. This is an opportunity to bring forward a new way of thinking.”
Clinical researchers are starting to realize advantages beyond simple economics and convenience for patients as they gain more experience conducting DCTs.